Pentraxin 3 deficiency protects from the metabolic inflammation associated to diet-induced obesity

Fabrizia Bonacina, Annalisa Moregola, Rémi Porte, Andrea Baragetti, Eduardo Bonavita, Alice Salatin, Liliana Grigore, Fabio Pellegatta, Martina Molgora, Marina Sironi, Elisa Barbati, Alberto Mantovani, Barbara Bottazzi, Alberico Luigi Catapano, Cecilia Garlanda, Giuseppe Danilo Norata

Research output: Contribution to journalArticle

Abstract

AIMS: Low-grade chronic inflammation characterizes obesity and metabolic syndrome. Here, we aim at investigating the impact of the acute-phase protein long pentraxin 3 (PTX3) on the immune-inflammatory response occurring during diet-induced obesity.

METHODS AND RESULTS: PTX3 deficiency in mice fed a high-fat diet for 20 weeks protects from weight gain and adipose tissue deposition in visceral and subcutaneous depots. This effect is not related to changes in glucose homeostasis and lipid metabolism but is associated with an improved immune cell phenotype in the adipose tissue of Ptx3 deficient animals, which is characterized by M2-macrophages polarization and increased angiogenesis. These findings are recapitulated in humans where carriers of a PTX3 haplotype (PTX3 h2/h2 haplotype), resulting in lower PTX3 plasma levels, presented with a reduced prevalence of obesity and decreased abdominal adiposity compared with non-carriers.

CONCLUSION: Our results support a critical role for PTX3 in the onset of obesity by promoting inflammation and limiting adipose tissue vascularization and delineate PTX3 targeting as a valuable strategy for the treatment of adipose tissue-associated inflammatory response.

Original languageEnglish
Pages (from-to)1861-1872
Number of pages12
JournalCardiovascular Research
Volume115
Issue number13
DOIs
Publication statusPublished - Nov 1 2019

    Fingerprint

Cite this